Nexilico is a biotech company focused on precision microbiome engineering through its innovative, modality-agnostic AI-driven discovery platform. Powered by its proprietary microbiome digital twin technology, Nexilico’s platform enables microbiome precision medicine and drives the development of diverse therapeutic strategies across a range of diseases. As a pioneer in next generation of in silico microbiome technologies, Nexilico is unlocking the full potential of the microbiome to address complex health challenges.
Copyright © 2024 Nexilico, Inc. - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.